Raleigh Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Buy
63,394
+6,624
+12% +$296K 0.86% 26
2026
Q1
$2.74M Buy
56,770
+14,212
+33% +$663K 0.94% 24
2025
Q4
$2.06M Buy
42,558
+1,643
+4% +$81.4K 0.75% 41
2025
Q3
$1.93M Buy
40,915
+1,535
+4% +$74.1K 0.73% 46
2025
Q2
$1.9M Buy
39,380
+1,081
+3% +$55.2K 0.8% 36
2025
Q1
$2.12M Buy
38,299
+5,864
+18% +$317K 0.96% 21
2024
Q4
$1.56M Sell
32,435
-406
-1% -$20.6K 0.6% 49
2024
Q3
$1.89M Sell
32,841
-558
-2% -$30.1K 0.73% 33
2024
Q2
$1.62M Buy
33,399
+6,491
+24% +$313K 0.69% 42
2024
Q1
$1.31M Buy
26,908
+6,362
+31% +$311K 0.56% 56
2023
Q4
$1.02M Sell
20,546
-6,947
-25% -$340K 0.47% 65
2023
Q3
$1.47M Sell
27,493
-73
-0.3% -$3.89K 0.75% 45
2023
Q2
$1.49M Buy
27,566
+4,264
+18% +$229K 0.74% 46
2023
Q1
$1.27M Buy
+23,302
New +$1.13M 0.63% 52
2022
Q1
Sell
-32
Closed -$2K 674
2021
Q4
$2K Buy
+32
New +$1.58K ﹤0.01% 273

Other funds holding SNY

Raleigh Capital Management's SNY Position: Q2 2026 in Review

Raleigh Capital Management increased its Sanofi (SNY) stake by 12% in Q2 2026, buying an estimated $296K and bringing the position to 63,394 shares worth $2.7M. The position accounts for 0.86% of the portfolio, ranked #26.

Raleigh Capital Management first reported a position in SNY in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.74M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Raleigh Capital Management held 63,394 shares of Sanofi worth $2.7M as of Q2 2026.
  • Raleigh Capital Management bought 6,624 Sanofi shares in Q2 2026, an estimated $296K.
  • Sanofi made up 0.86% of Raleigh Capital Management's portfolio in Q2 2026, its #26 holding.
  • Raleigh Capital Management first reported a position in Sanofi in Q4 2021 and has held it in 15 quarters since.
  • Raleigh Capital Management's Sanofi position peaked at $2.74M in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.